Business Wire

Miravo Healthcare™ Announces Third Quarter 2021 Results

- Q3 2021 Adjusted Total Revenue - $17.1 million - - Q3 2021 Adjusted EBITDA - $7.0 million - - Blexten Canadian Prescriptions Increased 16% Year-Over-Year - - Cambia Canadian Prescriptions Increased 5% Year-Over-Year - Miravo to Host Conference Call


Flora Growth Completes Acquisition of Vessel Brand Inc.

Acquisition provides Flora with an immediate foothold in the North American cannabis market by acquiring a rapidly growing company with trailing 12-months revenue of $6.6M and year-over-year growth of 90% Acquisition diversifies Flora’s premium bran